| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.079 | 0.2 |